Débora Lanznaster

1.1k total citations
37 papers, 852 citations indexed

About

Débora Lanznaster is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Débora Lanznaster has authored 37 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 19 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Débora Lanznaster's work include Amyotrophic Lateral Sclerosis Research (19 papers), Neurogenetic and Muscular Disorders Research (12 papers) and Adenosine and Purinergic Signaling (7 papers). Débora Lanznaster is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (19 papers), Neurogenetic and Muscular Disorders Research (12 papers) and Adenosine and Purinergic Signaling (7 papers). Débora Lanznaster collaborates with scholars based in France, Brazil and Spain. Débora Lanznaster's co-authors include Carla I. Tasca, Tharine Dal‐Cim, Hélène Blasco, Philippe Corcia, Patrick Vourc’h, Christian Andrés, Rudolf Hergesheimer, Tetsade Piermartiri, Dênis Reis de Assis and Adair R.S. Santos and has published in prestigious journals such as Nature reviews. Neuroscience, Brain and International Journal of Molecular Sciences.

In The Last Decade

Débora Lanznaster

36 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Débora Lanznaster France 18 344 290 155 145 139 37 852
Varsha Shukla United States 15 418 1.2× 58 0.2× 206 1.3× 224 1.5× 299 2.2× 31 1.1k
Tjerk Bueters Sweden 17 284 0.8× 93 0.3× 270 1.7× 54 0.4× 201 1.4× 40 1.0k
Katsura Takano Japan 18 407 1.2× 64 0.2× 147 0.9× 35 0.2× 203 1.5× 42 1.0k
Wenming Li China 24 788 2.3× 157 0.5× 323 2.1× 56 0.4× 419 3.0× 54 1.8k
Sang Yoon Lee South Korea 20 780 2.3× 55 0.2× 185 1.2× 133 0.9× 174 1.3× 44 1.6k
Daiju Tsuchiya Japan 16 300 0.9× 151 0.5× 202 1.3× 18 0.1× 253 1.8× 25 925
Carl B. Goodman United States 17 399 1.2× 61 0.2× 274 1.8× 17 0.1× 87 0.6× 39 959
Xiansi Zeng China 17 558 1.6× 228 0.8× 195 1.3× 20 0.1× 221 1.6× 34 1.1k
Shinghung Mak Hong Kong 22 458 1.3× 95 0.3× 209 1.3× 35 0.2× 265 1.9× 50 1.2k
Anindita Bose United States 8 530 1.5× 375 1.3× 202 1.3× 35 0.2× 206 1.5× 12 1.1k

Countries citing papers authored by Débora Lanznaster

Since Specialization
Citations

This map shows the geographic impact of Débora Lanznaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Débora Lanznaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Débora Lanznaster more than expected).

Fields of papers citing papers by Débora Lanznaster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Débora Lanznaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Débora Lanznaster. The network helps show where Débora Lanznaster may publish in the future.

Co-authorship network of co-authors of Débora Lanznaster

This figure shows the co-authorship network connecting the top 25 collaborators of Débora Lanznaster. A scholar is included among the top collaborators of Débora Lanznaster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Débora Lanznaster. Débora Lanznaster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vallet, Nicolas, Débora Lanznaster, Clément Bruno, et al.. (2025). Metabolomic and Proteomic Profiling of Serum-Derived Extracellular Vesicles from Early-Stage Amyotrophic Lateral Sclerosis Patients. Journal of Molecular Neuroscience. 75(1). 21–21. 2 indexed citations
2.
Richard, Élodie, Débora Lanznaster, Sylviane Marouillat, et al.. (2024). N-Terminal Fragments of TDP-43—In Vitro Analysis and Implication in the Pathophysiology of Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration. Genes. 15(9). 1157–1157. 1 indexed citations
3.
Marouillat, Sylviane, et al.. (2024). The effect of pH alterations on TDP-43 in a cellular model of amyotrophic lateral sclerosis. Biochemistry and Biophysics Reports. 38. 101664–101664. 1 indexed citations
4.
Andrés, Christian, Débora Lanznaster, Sylviane Marouillat, et al.. (2023). Study of Ubiquitin Pathway Genes in a French Population with Amyotrophic Lateral Sclerosis: Focus on HECW1 Encoding the E3 Ligase NEDL1. International Journal of Molecular Sciences. 24(2). 1268–1268. 3 indexed citations
5.
Lanznaster, Débora, Jean‐Michel Escoffre, Philippe Corcia, et al.. (2022). Taking Advantages of Blood–Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?. Journal of Personalized Medicine. 12(7). 1071–1071. 10 indexed citations
6.
Lanznaster, Débora, Clément Bruno, Jérôme Bourgeais, et al.. (2022). Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis. Biomedicines. 10(6). 1307–1307. 11 indexed citations
7.
Lanznaster, Débora, Rudolf Hergesheimer, Patrick Vourc’h, Philippe Corcia, & Hélène Blasco. (2021). TDP43 aggregates: the ‘Schrödinger’s cat’ in amyotrophic lateral sclerosis. Nature reviews. Neuroscience. 22(8). 514–514. 5 indexed citations
8.
Denevault‐Sabourin, Caroline, Nicolas Joubert, Jean‐Pierre Pouget, et al.. (2021). Therapeutic antibodies – natural and pathological barriers and strategies to overcome them. Pharmacology & Therapeutics. 233. 108022–108022. 22 indexed citations
9.
Lanznaster, Débora, Théodora Bejan‐Angoulvant, Jorge Gandía, Hélène Blasco, & Philippe Corcia. (2020). Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis. Frontiers in Neurology. 11. 697–697. 12 indexed citations
10.
Lanznaster, Débora, et al.. (2019). Adenosine A1-A2A Receptor-Receptor Interaction: Contribution to Guanosine-Mediated Effects. Cells. 8(12). 1630–1630. 27 indexed citations
11.
Zanatta, Ana Paula, Renata Gonçalves, Leïla Zanatta, et al.. (2019). New ionic targets of 3,3′,5′-triiodothyronine at the plasma membrane of rat Sertoli cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1861(4). 748–759. 6 indexed citations
12.
13.
Lanznaster, Débora, Franciane Bobinski, Tuane Bazanella Sampaio, et al.. (2018). Intranasal administration of sodium dimethyldithiocarbamate induces motor deficits and dopaminergic dysfunction in mice. NeuroToxicology. 66. 107–120. 13 indexed citations
14.
Tasca, Carla I. & Débora Lanznaster. (2017). Targeting the guanine-based purinergic system in Alzheimer's disease. Neural Regeneration Research. 12(2). 212–212. 3 indexed citations
15.
Castro, Adalberto A., et al.. (2016). In vitro 6-hydroxydopamine-induced toxicity in striatal, cerebrocortical and hippocampal slices is attenuated by atorvastatin and MK-801. Toxicology in Vitro. 37. 162–168. 23 indexed citations
16.
Lanznaster, Débora, Tharine Dal‐Cim, Tetsade Piermartiri, & Carla I. Tasca. (2016). Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders. Aging and Disease. 7(5). 657–657. 98 indexed citations
17.
Lanznaster, Débora, Marcelo Ganzella, Roberto Farina Almeida, et al.. (2016). Guanosine Prevents Anhedonic-Like Behavior and Impairment in Hippocampal Glutamate Transport Following Amyloid-β1–40 Administration in Mice. Molecular Neurobiology. 54(7). 5482–5496. 45 indexed citations
18.
Dal‐Cim, Tharine, Wagner C. Martins, Maurício P. Cunha, et al.. (2016). Guanosine prevents nitroxidative stress and recovers mitochondrial membrane potential disruption in hippocampal slices subjected to oxygen/glucose deprivation. Purinergic Signalling. 12(4). 707–718. 27 indexed citations
19.
Lanznaster, Débora, et al.. (2012). Anti-inflammatory effect of triterpene 3β, 6β, 16β-trihydroxylup-20(29)-ene obtained from Combretum leprosum Mart & Eich in mice. Journal of Ethnopharmacology. 142(1). 59–64. 41 indexed citations
20.
Martins, Daniel F., et al.. (2010). Further analyses of mechanisms underlying the antinociceptive effect of the triterpene 3β, 6β, 16β-trihydroxylup-20(29)-ene in mice. European Journal of Pharmacology. 653(1-3). 32–40. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Varsha Shukla Breakdown of academic impact, for papers by Tjerk Bueters Breakdown of academic impact, for papers by Katsura Takano Breakdown of academic impact, for papers by Wenming Li Breakdown of academic impact, for papers by Sang Yoon Lee Breakdown of academic impact, for papers by Daiju Tsuchiya Breakdown of academic impact, for papers by Carl B. Goodman Breakdown of academic impact, for papers by Xiansi Zeng Breakdown of academic impact, for papers by Shinghung Mak Breakdown of academic impact, for papers by Anindita Bose
Rankless by CCL
2026